[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100501440":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":13,"locations":19,"responsibleParty":58,"collaborators":7,"id":60,"slug":61,"hasResults":62,"nctId":63,"briefTitle":64,"officialTitle":64,"acronym":65,"eligibilityCriteria":66,"healthyVolunteers":62,"sex":67,"minAge":7,"maxAge":68,"enrollmentInfo":69,"targetDuration":7,"studyType":72,"phases":7,"briefSummary":73,"conditions":74,"keywords":7,"overallStatus":22,"whyStopped":7,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":88,"locationsCount":89},{"fullName":5,"class":6},"University College, London","OTHER",null,[9],{"name":10,"affiliation":11,"role":12},"Persis Amrolia, BSc,MBBS,PhD","UCL Institute of Child Health","STUDY_CHAIR",[14],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},"CARPERS Trial Manager","CONTACT","442031084189","ctc.carpers@ucl.ac.uk",[20,37,46],{"facility":21,"status":22,"city":23,"state":7,"zip":7,"country":24,"countryCode":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":32},"Great Ormond Street Hospital","RECRUITING","London","United Kingdom","UK",{"type":27,"coordinates":28},"Point",[29,30],-0.12574,51.50853,{"lat":30,"lon":29},[33,35],{"name":34,"role":16,"phone":7,"phoneExt":7,"email":7},"Persis Amrolia",{"name":34,"role":36,"phone":7,"phoneExt":7,"email":7},"PRINCIPAL_INVESTIGATOR",{"facility":38,"status":22,"city":23,"state":7,"zip":7,"country":24,"countryCode":25,"cosmosGeoPoint":39,"geoPoint":41,"contacts":42},"University College London Hospital",{"type":27,"coordinates":40},[29,30],{"lat":30,"lon":29},[43,45],{"name":44,"role":16,"phone":7,"phoneExt":7,"email":7},"Rachael Hough",{"name":44,"role":36,"phone":7,"phoneExt":7,"email":7},{"facility":47,"status":22,"city":48,"state":7,"zip":7,"country":24,"countryCode":25,"cosmosGeoPoint":49,"geoPoint":53,"contacts":54},"Royal Manchester Children's Hospital","Manchester",{"type":27,"coordinates":50},[51,52],-2.23743,53.48095,{"lat":52,"lon":51},[55,57],{"name":56,"role":16,"phone":7,"phoneExt":7,"email":7},"Denise Bonney",{"name":56,"role":36,"phone":7,"phoneExt":7,"email":7},{"type":59,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100501440","determining-the-mechanisms-of-loss-of-car-t-cell-persistence-100501440",false,"NCT05809284","Determining the Mechanisms of Loss of CAR T Cell Persistence","CARPERS","Inclusion Criteria:\n\n1. Children and young adults (age 25 years or younger) with relapsed\u002Frefractory ALL who are planned to receive licensed CD19-targeted CAR-T cell treatment (Tisagenlecleucel)\n2. Written informed consent\n\nExclusion Criteria:\n\n1. Patients receiving an alternate CD19-directed CAR T-cell product on a clinical trial\n2. Any reason that in the opinion of the investigator, patients won't be able to adhere to the protocol","ALL","25 Years",{"count":70,"type":71},50,"ESTIMATED","OBSERVATIONAL","A prospective observational study of pediatric and young adult acute lymphoblastic leukaemia (ALL) patients treated with CD19 chimeric antigen receptor T-cells (CAR-T cells). The study will examine changes in CAR-T persistence over time and causal factors.",[75,76,77,78,79],"Acute Lymphoblastic Leukemia With Failed Remission","Acute Lymphoblastic Leukemia Not Having Achieved Remission","Acute Lymphoblastic Leukemia, Pediatric","Acute Lymphoblastic Leukemia, Adult","Acute Lymphoblastic Leukemia, in Relapse","2026-08-06",{"date":82,"type":83},"2026-08-07","ACTUAL",{"date":85,"type":83},"2023-10-18",{"date":87,"type":71},"2027-07-01",{"name":5,"class":6},3]